Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GI 5005

Drug Profile

GI 5005

Alternative Names: GI-5005; Tarmogen

Latest Information Update: 14 Sep 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GlobeImmune
  • Class Antivirals; Hepatitis C vaccines
  • Mechanism of Action Immunostimulants; T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hepatitis C

Most Recent Events

  • 03 Nov 2010 GlobeImmune receives grants under the Federal Therapeutics Discovery Projects programme for GI 5005 development in Hepatitis C
  • 30 Oct 2010 Efficacy data from a phase IIb trial (GI-5005-02) in Hepatitis C presented at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2010)
  • 28 Oct 2010 GlobeImmune expands phase IIb trial (GI-5005-02) for treatment-naive Hepatitis C to include patients with IL28B T/T genotype
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top